In vitro studies using a vemurafenib-resistant melanoma A375 cell line have shown a lower expression of RB1 transcripts and pRB than the vemurafenib-sensitive A375 cells (Figure 7A–7C and Supplementary Figure 4A). The gene discussed is RB1; the disease is melanoma.